Black Bird Biotech, Inc. (BBBT)

Market Cap	3.73K
Revenue (ttm)	36.32K -61.0%
Net Income	-836.14K
EPS	-0.00
Shares Out	3.73B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60,000
Open	0.000001
Previous Close	0.000001
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0001
Beta	1.95
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 20, 2026

About Black Bird Biotech

Black Bird Biotech, Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. The company also manufactures and sells CBD Oils, gummies and pet treats, CBD-infused personal care products, and hand sanitizer under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program. The company was formerly known as Digital Development Partners, Inc. and changed its name to Black Bird Biotech, Inc. in June 2021....

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Nelson Grist
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: BBBT

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 9, 2026

Data Sources Report a data error